Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency

NCT03218384 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Unable to complete enrollment as planned.

Conditions

Iron-deficiency

Interventions

DRUG: Ferric Carboxymaltose
DRUG: Placebo
DEVICE: 31P MRS/MRI

Sponsor

NYU Langone Health